STK3 is a therapeutic target for a subset of acute myeloid leukemias.
Camgoz A, Paszkowski-Rogacz M, Satpathy S, Wermke M, Hamann MV, von Bonin M, Choudhary C, Knapp S, Buchholz F.
Camgoz A, et al. Among authors: knapp s.
Oncotarget. 2018 May 22;9(39):25458-25473. doi: 10.18632/oncotarget.25238. eCollection 2018 May 22.
Oncotarget. 2018.
PMID: 29876001
Free PMC article.